Citation Impact
Citing Papers
Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment
2013 Standout
SYRCLE’s risk of bias tool for animal studies
2014 Standout
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
2010 Standout
Recommendations from the international evidence‐based guideline for the assessment and management of polycystic ovary syndrome
2018 Standout
Methodology in conducting a systematic review of systematic reviews of healthcare interventions
2011 Standout
The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study
2005
Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins
1997
Medical-eligibility criteria for contraceptive use
2001 Standout
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
2004 Standout
Thiazolidinediones
2004 Standout
The Treatment of Endometriosis
2002
Pregnancy complications in PCOS
2006
Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
2005
Endometrium in PCOS: Implantation and predisposition to endocrine CA
2006
What is polycystic ovarian syndrome?: A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome
2002
Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials
1998
Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome
1992
The management of insulin resistance in polycystic ovary syndrome
2007
Infertility and the provision of infertility medical services in developing countries
2008
Endometriosis
2009 Standout
Gonadotrophin and gonadal steroid response to a single dose of a long‐acting agonist of gonadotrophin‐releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome
1995
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome
2002
DIET‐INDUCED CHANGES IN SEX HORMONE BINDING GLOBULIN AND FREE TESTOSTERONE IN WOMEN WITH NORMAL OR POLYCYSTIC OVARIES: CORRELATION WITH SERUM INSULIN AND INSULIN‐LIKE GROWTH FACTOR‐I
1989
Reproductive healthcare systems should include accessible infertility diagnosis and treatment: An important challenge for resource‐poor countries
2009
DIFFERENCES IN CLINICAL AND ENDOCRINE FEATURES BETWEEN OBESE AND NON‐OBESE SUBJECTS WITH POLYCYSTIC OVARY SYNDROME: AN ANALYSIS OF 263 CONSECUTIVE CASES
1990
Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial
1996
Polycystic ovaries and recurrent miscarriage—a reappraisal
2000
Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study1
1998 Standout
The physiology and clinical utility of anti-Müllerian hormone in women
2014 Standout
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
2011
Prospective evaluation of two stimulation protocols for low responders who were undergoing in vitro fertilization–embryo transfer
2003
The modern preventative treatment of recurrent miscarriage
1996
Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians
2017 Standout
Smoking induces oxidative stress inside the Graafian follicle
2002
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques
2000
Follicular dynamics in the polycystic ovary syndrome
2000
A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization
2004
Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study
2004
The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome
1998
EMX2 Gene Expression in the Female Reproductive Tract and Aberrant Expression in the Endometrium of Patients with Endometriosis
2004 Standout
Polycystic Ovary Syndrome
1995 Standout
Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?
2005
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
8 Definition and significance of polycystic ovaries
1997
Contraception
2000
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Evidence for a single gene effect causing polycystic ovaries and male pattern baldness
1993
Long-term consequences of polycystic ovary syndrome: Results of a 31 year follow-up study
2000
Environmental Contaminants and Human Infertility: Hypothesis or Cause for Concern?
2008
POLYCYSTIC OVARY SYNDROME: A CHANGING PERSPECTIVE
1989
Health-Related Quality of Life in Adolescents and Young Adults with Polycystic Ovary Syndrome: A Systematic Review
2016
Effects of Metformin on Early Pregnancy Loss in the Polycystic Ovary Syndrome
2002
The Prevalence of Polycystic Ovaries on Ultrasound Scanning in a Population of Randomly Selected Women
1994
Cessation of Gonadotropin-Releasing Hormone Agonist Therapy Combined with High-Dose Gonadotropin Stimulation Yields Favorable Pregnancy Results in Low Responders
1998
Polycystic Ovary Syndrome
2005 Standout
Systematic Review and Meta-analysis
2008 Standout
Role of reactive oxygen species in the pathophysiology of human reproduction
2003 Standout
The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance
2016
Treatment of Endometriosis
2001
AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews
2009
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
2017 Standout
Ultrasound diagnosis of polycystic ovaries in women who have no symptoms of polycystic ovary syndrome is not associated with subfecundity or subfertility
2003
Fecundability and spontaneous abortions in women with self-reported oligo-amenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study
2008
Insulin-Lowering Drugs In Polycystic Ovary Syndrome
2001
Endometriosis
2004 Standout
Polycystic ovary syndrome
1997
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Assessment and management of anovulatory infertility in polycystic ovary syndrome
2003
A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization
2005
Men at risk: occupation and male infertility
2004 Standout
Altered glucose disposition and insulin sensitivity in peri-pubertal first-degree relatives of women with polycystic ovary syndrome
2012
Recurrent miscarriage
2006 Standout
Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century
2015 Standout
Derivation of Functional Antagonists Using N-Terminal Extracellular Domain of Gonadotropin and Thyrotropin Receptors
1997 StandoutNobel
Polycystic ovary syndrome
2016 Standout
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
2011 Standout
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women1
1999 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin
1992
Polycystic ovarian syndrome: safety and effectiveness of stepwise and low-dose administration of purified follicle-stimulating hormone
1991
Basic Infertility Including Polycystic Ovary Syndrome
2008
Polycystic ovarian syndrome: a follow-up study on fertility and menstrual pattern in 149 patients 15-25 years after ovarian wedge resection
2001
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
The plasminogen activator system in women with polycystic ovary syndrome
1998
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Polycystic Ovary Syndrome (PCOS): Arguably the Most Common Endocrinopathy Is Associated with Significant Morbidity in Women
1999
GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial
2004
Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
2008
Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews
2007 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
An evaluation of the inter-observer and intra-observer variability of the ultrasound diagnosis of polycystic ovaries
2002
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria
2009 Standout
Steroid Receptor Coactivator Expression throughout the Menstrual Cycle in Normal and Abnormal Endometrium
2002
Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
2008
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
MANAGEMENT OF ENDOCRINE DISEASE: Secondary polycystic ovary syndrome: theoretical and practical aspects
2016
Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles
2011
Health Consequences of Obesity in Youth: Childhood Predictors of Adult Disease
1998 Standout
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Synthesizing information systems knowledge: A typology of literature reviews
2014 Standout
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Anti-Mullerian Hormone Protein Expression Is Reduced during the Initial Stages of Follicle Development in Human Polycystic Ovaries
2005
12 Common problems in induction of ovulation
1990
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
1997 Standout
How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study
2003 Standout
Molecular Abnormalities in Oocytes from Women with Polycystic Ovary Syndrome Revealed by Microarray Analysis
2006
Evaluating non-randomised intervention studies
2003 Standout
Early origins of polycystic ovary syndrome
2005
Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses.
1999
Regulation of HOXA-10 Expression by Testosterone in Vitro and in the Endometrium of Patients with Polycystic Ovary Syndrome
2003
A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain1
2000 Standout
Manipulation of Human Ovarian Function: Physiological Concepts and Clinical Consequences*
1997
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Prospective Parallel Randomized, Double-Blind, Double-Dummy Controlled Clinical Trial Comparing Clomiphene Citrate and Metformin as the First-Line Treatment for Ovulation Induction in Nonobese Anovulatory Women with Polycystic Ovary Syndrome
2005
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Changes in Serum Anti-Mullerian Hormone Level during Low-Dose Recombinant Follicular-Stimulating Hormone Therapy for Anovulation in Polycystic Ovary Syndrome
2007
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
2016
Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses
2001 Standout
Works of M. Sagle being referenced
RECOVERY OF LUTEAL FUNCTION AFTER INTERRUPTION OF GONADOTROPHIN SECRETION IN THE MID‐LUTEAL PHASE OF THE MENSTRUAL CYCLE
1987
A double‐blind randomised controlled trial of the effects of medroxyprogesterone acetate on bone density of women taking oestrogen replacement therapy
1997
REDUCED FREQUENCY OF LUTEINIZING HORMONE PULSES IN WOMEN WITH WEIGHT LOSS‐RELATED AMENORRHOEA AND MULTIFOLLICULAR OVARIES
1988
Use of LHRH Agonists in the Treatment of Anovulation in Women with Polycystic Ovary Syndrome
1987
Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome
1991
The Impact of Bariatric Surgery on Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis
2015
Infertility: Natural cycles for in-vitro fertilization: cost-effectiveness analysis and factors influencing outcome*
1995
A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome
1991
The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials
1992
Use of Metformin for Ovulation Induction in Women Who Have Polycystic Ovary Syndrome With or Without Evidence of Insulin Resistance
2006
Recurrent early miscarriage and polycystic ovaries.
1988
Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: a meta-analysis
1995
Cigarette smoking and the outcomes of in vitro fertilization: measurement of effect size and levels of action
1994